the possible benefits of tumor-informed mrd for patients with sarcoma
Published 1 year ago • 36 plays • Length 1:01Download video MP4
Download video MP3
Similar videos
-
0:52
using tumor-informed mrd to find biomarkers in cancer
-
1:07
ctdna mrd detection in patients with nsclc
-
0:38
personalized medicine for patients with gynecological sarcoma
-
3:30
ctdna as an mrd biomarker for nsclc
-
2:53
the emerging role of mrd in colorectal cancer decision making
-
7:53
ctdna mrd detection from plasma and urine in colorectal cancer
-
1:20
unmet needs in the field of sarcoma
-
4:34
endometrial cancer uterus fda approved treatment - dr robert debernardo, md
-
3:43
evolving applications of ctdna in lung cancer: mrd, early detection, and molecular profiling
-
3:04
first real-world ctdna analysis of oligometastic crc
-
4:31
cobra: ctdna to help decide which patients with colon cancer will benefit from adjuvant chemotherapy
-
8:45
ctdna as a novel biomarker for mrd in crc
-
2:02
applications of ctdna in lung cancer: informing treatment approaches, mrd and screening
-
5:13
how can ctdna assess mrd and profile tumor types in lung cancer?
-
6:58
personalizing ctdna analysis to predict crc relapse
-
2:05
challenges to be overcome in the use of ctdna for colon cancer treatment
-
2:47
real-world monitoring of ctdna reliably predicts cancer recurrence in resected stages i-iii crc
-
1:07
dr. randall of tumor sequencing research in sarcomas
-
1:36
liquid biopsies and tumor-informed ctdna profiling in metastatic urothelial carcinoma